Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.

Dominguez D, Vaclaw S, McClard CK, Jeffries MA, Noori J

Open source

DOI
10.18502/jovr.v20.14952
Published
2025
Container
Journal of ophthalmic & vision research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18502/jovr.v20.14952,
  title = {Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.},
  author = {Dominguez D and Vaclaw S and McClard CK and Jeffries MA and Noori J},
  year = {2025},
  journal = {Journal of ophthalmic \& vision research},
  doi = {10.18502/jovr.v20.14952},
  url = {https://doi.org/10.18502/jovr.v20.14952}
}

RIS

TY  - JOUR
TI  - Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.
AU  - Dominguez D
AU  - Vaclaw S
AU  - McClard CK
AU  - Jeffries MA
AU  - Noori J
PY  - 2025
JO  - Journal of ophthalmic & vision research
DO  - 10.18502/jovr.v20.14952
UR  - https://doi.org/10.18502/jovr.v20.14952
ER  - 

APA

D, D., S, V., CK, M., MA, J., & J, N. (2025). Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.. Journal of ophthalmic & vision research. https://doi.org/10.18502/jovr.v20.14952

Source records